...

 
Cannvas.Me
Sign Up For Free
  • Post Time Posted October 11, 2018
The U.S. Food and Drug Administration (FDA) is seeking the public’s opinion on the “abuse potential, actual abuse, medical usefulness, trafficking, and impact of scheduling changes on availability for medical use” of cannabis. 

Under U.S. federal law and global drug policy agreements, marijuana is currently classified at the most restrictive level, meaning that technically nations who sign drug treaties are not supposed to legalize it. 

Marijuana’s international drug classification may change however, as the reason for the public comments is to be considered in the United States response to the World Health Organization regarding the abuse liability and diversion of the drug. The WHO will then use the information it gathers from its members to possibly reclassify marijuana when the WHO’s Expert Committee on Drug Dependence (ECDD) meets in Geneva next month.
 
The meeting is coming after the ECDD determined that CBD should not be a scheduled drug under international treaties earlier this year. The committee then recommended that preparations be considered to declassify it completely, and will also look at the marijuana plant and its extracts to determine if it too should continue to be restricted. 

Source: https://www.forbes.com/sites/tomangell/2018/10/10/trump-administration-seeks-public-comments-on-marijuana-reclassification/#3b2d9d1749ad

This article is now marked as read.

Was this article helpful?

Review this article to help us continue creating and sharing relevant content.

Please note it may take up to two business days for reviews to be validated and published.

Reviews

Review this article to help us continue creating and sharing relevant content.

Write Review

Would you like to
make this review public?

Please disable your ad blocker to avoid issues using social plugins on Cannvas.Me. Thanks.
Close